Literature DB >> 11699028

Neurotoxicity of immunosuppressive drugs.

E F Wijdicks1.   

Abstract

The clinical profile of neurotoxicity caused by immunosuppression has changed. When toxic levels are reached, both cyclosporine and tacrolimus may produce a clinical spectrum that varies from tremor and acute confusional state to status epilepticus and major speech or language abnormalities. Coma has become an unusual manifestation. Magnetic resonance imaging has been better defined, and abnormalities may be more widespread than those in the posterior lobes. These white matter lesions are caused by vasogenic edema, but may lead to apoptosis and cytotoxic edema if exposure is prolonged. Recent evidence suggests inhibition of a drug-efflux pump and dysfunction of the blood-brain barrier by enhanced nitric oxide production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699028     DOI: 10.1053/jlts.2001.27475

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  42 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  [Case of inflammatory vasculopathy and encephalopathy caused by treatment with tacrolimus].

Authors:  Adrian Ringelstein; Katja Bongs; Burkhard Sorge-Hädicke; Peter Berlit
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

Review 3.  Neurologic complications after liver transplantation.

Authors:  Saša A Zivković
Journal:  World J Hepatol       Date:  2013-08-27

4.  Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma.

Authors:  Mithri R Junna; Alejandro A Rabinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

Review 5.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

6.  Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation.

Authors:  Lilian Schwarz; François Cauchy; Filomena Conti; Ailton Sepulveda; Fabiano Perdigao; Denis Bernard; Yvon Calmus; Olivier Soubrane; Olivier Scatton
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

7.  Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation.

Authors:  L Chavarria; J Alonso; R García-Martínez; F X Aymerich; E Huerga; C Jacas; V Vargas; J Cordoba; A Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

Review 8.  The neurology of solid organ transplantation.

Authors:  J David Avila; Saša Živković
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 9.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

10.  Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.

Authors:  Uwe Christians; Sven Gottschalk; Jelena Miljus; Carsten Hainz; Leslie Z Benet; Dieter Leibfritz; Natalie Serkova
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.